Timbao, Fausto M.

HRN: 28-80-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/09/2026
04/16/2026
IV
4.5g
Q6
Cap-HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: